secwatch / observer
8-K filed September 10, 2024, 7:59 PM ET ticker AVAI CIK 0001740797
other material confidence high sentiment negative materiality 0.70

Avant Tech terminates $2.2M Wired4Health asset purchase; CFO replaced

AVAI BIO, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

William Hisey

Chief Financial Officer
AVAI · AVAI BIO, INC.
Effective
2024-09-09
Successor
Vitalis Racius
Filed
September 10, 2024, 7:59 PM ET
Effective September 9, 2024, Mr. Hisey vacated his position as Chief Financial Officer (the “CFO”) of the Company.
Appointed

Vitalis Racius

Chief Financial Officer
AVAI · AVAI BIO, INC.
Effective
2024-09-09
Filed
September 10, 2024, 7:59 PM ET
Mr. Racius, the current Chief Operating Officer (the “COO”), Director, and Treasurer, was reappointed as the Company's Chief Financial Officer (the “CFO”) while continuing his roles as Director and Treasurer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William Hisey resigned as Chief Financial Officer at AVAI BIO, INC..

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
Effective September 9, 2024, Mr. Hisey vacated his position as Chief Financial Officer (the “CFO”) of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Vitalis Racius was appointed as Chief Financial Officer at AVAI BIO, INC..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Mr. Racius, the current Chief Operating Officer (the “COO”), Director, and Treasurer, was reappointed as the Company's Chief Financial Officer (the “CFO”) while continuing his roles as Director and Treasurer.
View on SEC.gov

AVAI BIO, INC. filing history →

Source: SEC EDGAR
accession 0001740797-24-000047
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.